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INT RO D UCT IO N
Mature peripheral T lymphocytes generally undergo cell
death when stimulated with monoclonal antibodies aga-
inst CD3/TCR complex and phytohemagglutinin (PHA)1) .
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This process is rapid and exhibits classic characteristics
of apoptosis , such as membrane blebbing, chromatin
condensation and the formation of DNA fragmentations
of -200bp. Deletion of T lymphocytes by apoptosis ap-
pears to be important not only in regulating autoreactive
T lymphocytes in the thymus, but also in regulating the
peripheral T lymphocytes pool2 , 3 ) .
Fas antigen is a type I membrane protein belonging to
the tumor necrosis factor (TNF)/nerve growth factor
(NGF) receptor family4 ) . Crosslinking with antibody against
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human Fas antigen induces apoptosis of cells expressing
Fas antigen. From these results , it was concluded that
Fas antigen transduces an apoptotic signal into cells , and
that anti- Fas antibody works as an agonist for the Fas
antigen.
In vitro and in vivo results suggest the involvement of
the Fas system in the clonal deletion of autoreactive T
lymphocytes in the periphery5 ) . Mutation in the Fas-
encoding gene is responsible for the lymphoproliferative
disorder and associated lupuslike syndrome in lpr and
lprcg mice6 ) . Defects in Fas- induced apoptosis lead to
the incomplete elimination of peripheral autoreactive cells
in these mice.
High response rates to immunosuppressive therapy
(IST) have suggested that acquired aplastic anemia (AA)
is an immune- mediated process7 - 9 ) . Activated cytotoxic T
lymphocytes and their soluble products are possible final
effecters for hematopoietic injuryl0 )
Based on the importance of activation- induced cell
death (AICD) in autoimmune disease and autoimmune
phenotype of AA, we speculated that the abnormal AICD
of T lymphocytes in AA might inhibit e limination of
activated T lymphocytes and thereby cause the AA
phenotype. We investigated both T lymphocytes death
and Fas antigen expression by activation in AA, and also
compared the res ults of patients with recovered AA.
MA T E R IA LS A ND MET HO DS
1. Patients
This study included 20 patients with aplastic anemia
(l3 newly diagnosed, 7 recovered AA after IST) who were
admitted between J une 1995 and March 1996, and 6
normal controls . We studied the expression of Fas
antigen on fresh T lymphocytes of all patients , and inve-
stigated the AICD and Fas expression by activation in 5
newly- diagnosed AA, 5 normal controls and 5 AA in
complete response (CR).
2. Pre paration of T lymphocytes
Peripheral blood samples were obtained from patients
with newly- diagnosed severe AA, patients with AA in CR
after IST and normal controls . Peripheral blood mononu-
clear cells were isolated from heparinized peripheral
blood by Ficoll- Hypaque density gradient centrifugation.
Then CD2+ cells were prepared by immunomagnetic
bead methods , as described in detail e lsewhere 1 1) . The
s ubsets prepared in this way were regularly 90- 98%
positive for CD2 or CD3 phenotype.
3. T lymphocytes activation
T lymphocytes were cultured with a RPMI- 1640 me-
dium s upplemented with L- glutamine, 50 U/ml penicillin
G, 50 ㎍/ml streptomycin and 10% of FBS at a concen-
tration of 1.5× 106 cells/ml at 37℃ , 5% CO2 for the times
indicated. Interleukin- 2 (IL- 2)(Eurocetus, UK) and PHA
(Sigma, USA) were present at a concentration of 200
U/ml and 50 ㎍/ml, respectively. Media, IL-2 and PHA
were replenished every 3 days and cell numbers were
readjusted.
4. Flow cytometric a nalysis
Fas antigen expression of T lymphocytes by activa-
tion was investigated using fluorescein isothiocyanate conju-
gated anti- Fas monoclonal antibody (IgG; UBI, NY, USA).
5. Quantitation of AICD
We used the cell death detection ELISA kit (Boehrin-
ger Manheim, Germany) for the quantitation of cell death.
This assay is based on the quantitative sandwich-
enzyme- immunoassay principle using mouse monoclonal
antibodies directed against DNA and histones, respec-
tively. This allows for the specific determination of mono-
and oligonucleosomes in the cytoplas mic fraction of cell
lysates . Briefly, at the time intervals indicated, 1× 104
cells were removed from culture and pelleted by
centrifugation. The cell pellets were resuspended with
500 ㎕ incubation buffer and incubated for 30 min at 4℃ .
After centrifugation, 400 ㎕ supernants were obtained
and the resulting supernants were prediluted 1:3 with
incubation buffer. These sample solutions were added to
anti- histone antibody (cion H 11- 4; Boehringer Manheim)
coated microtiter plates (MTP). After incubation for 90
min at room temperature, 100 ㎕ of anti- DNA peroxidase
were added to each MTP. Then, 100 ㎕ of ABTS
solution (Boehringer Manheim) were added and absor-
bance was measured at 405 nm.
6. Ana lys is of DNA fragme ntation
To assess DNA fragmentation following activation, ge-
nomic DNA was isolated from 3- day activated T lympho-
cytes. Briefly, at 3 days of activation, 2× 106 cells were
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washed in PBS and pelleted in Eppendorf tubes, lysed in
0.5 ml of lysis buffer (10 mM EDTA; 50 mM Tris- HCI,
pH 8; 1% SDS; and 250 ㎍/ml of proteinase K) and
incubated for 60 min at 50℃ . Nucleic acids were ex-
tracted from the digested lysates by phenol/chloroform
extraction method and then precipitated overnight with
cold 100% ethanol at - 20℃ . Nucleic acid precipitates
were centrifuged for 15 min at 2000×g, vacuum dried
and resuspended in -20℃ ㎕ of TE buffer and incubated
with 250 ㎍/ml of RNase at 65℃ for 5 min to remove
RNA. Electrophoresis of the res ulting DNA samples was
carried out at 5 V/cm in 2% agarose gels made in TBE
buffer containing 0.5 ㎍/ml of ethidium bromide. Frac-
tionated DNA was vis ualized by exposure to UV light and
photographed.
7. Anti-Fas Ab sensitivity of activated T lymphocytes
At 3 days of activation, T lymphocytes were removed
from culture, pelleted by centrifugation and resuspended
at a concentration of 1× 104 cells/ml in original media.
Anti- human Fas Ab (IgM; UBI, NY, USA) was added at
a final concentration of 500 ng/ml and the cells were
cultured for the times indicated at 37℃ . After incubation,
cell death was quantitated as described earlier.
R E S ULT S
1. Expression of Fas antigen on fresh lymphocytes
Before the investigation of cell death and Fas antigen
expression by activation, we analyzed the baseline
expression of Fas antigen on T lymphocytes. There was
no significant difference of Fas antigen expression on
freshly- isolated T lymphocytes among newly- diagnosed
severe AA, normal controls and patients with AA in CR
after IST (Fig. 1).
2. Quantitation of T lymphocytes death by activation
In normal controls , death of T lymphocytes was
greatly increased at 3 days of activation. Patients with
AA in CR showed a similar cell- death pattern, i.e ., s igni-
ficant enhancement of cell death at 3 days of activation.
In contrast, newly- diagnosed AA patients did not s how
the enhancement of cell death at 3 days of activation,
but enhancement of cell death was noted at 7 days of
activation (Fig. 2)
Fig . 1. Expression of Fas antigen on T lymphocytes. Each
dot represents one patient or control sample ana-
lyzed. The values correspond to the percentage of
Fas+CD3+ within tota l CD3+ cells . The mean per-
centage of CD3+ express ing Fas antigen in the
newly- diagnosed AA patients (n=13) was 29.9%,
34.9% in normal controls (n=6), and 35.3% in re-
covered AA patients (n=7). There was no signifi-
cant difference of Fas antigen expression on T ly-
mphocytes between each group.
Fig . 2 . Quantitation of activated T lymphocytes death by
enzyme- immunoassay using anti- histone antibody
and anti- DNA antibody against mono- and oligonu-
cleosomes. Each data point represents the mean
absorbance (mU)±SEM of T lymphocytes death
from 5 newly- diagnosed AA, 5 normal controls
and 5 AA in CR at the time intervals indicated.
3 . Express ion of Fas a ntigen on activated T
lymphocytes
In addition to quantitation of T lymphocytes death by
activation, we examined the Fas antigen expression by T
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lymphocytes at the same time intervals to correlate
cell- death pattern with Fas antigen express ion by activa-
tion. In normal controls and patients with AA in CR, Fas
antigen expression on T lymphocytes was increased above
baseline at day 1 of activation. But newly- diagnosed AA
patients did not s how any increase of Fas antigen ex-
pression of T lymphocytes at day 1 of activation, but en-
hanced Fas antigen express ion at day 3 of activation
(Fig. 3).
Fig . 3 . Expression of Fas antigen on T lymphocytes by
activation. The percentage of T lymphocytes posi-
tive for Fas antigen was determined using flow
cytometric immunufluorescence. Each data point
represents the mean percentage ±SEM of T ly-
mphocytes expressing Fas antigen from 5 newly-
diagnosed AA, 5 normal controls and 5 AA in CR
at the time intervals indicated.
4 . Anti-Fas a ntibody sens itivity of activated T lym-
phocytes
To investigate the difference of Fas- mediated death of
activated T lymphocytes between each group, we treated
the anti- fas antibody to T lymphocytes at 3 days of
activation, and analyzed the time- course kinetics of
induction of cell death by anti- Fas antibody. In normal
controls and patients with AA in CR, activated T lym-
phocytes acquired significantly increased sensitivity to the
anti- Fas antibody at 6 hours of treatment, while a reduc-
ed degree of sensitivity increment to anti- Fas antibody
was noted in newly- diagnosed AA patients (Fig. 4).
5. Docume ntation of DNA fragme ntation
In all groups, activated T lymhpocytes showed charac-
teristic DNA fragmentation at day 3 of activation(Fig. 5.)
Fig . 4 . Time course kinetics of anti- fas antibody sensitivity
at day 3 of activated lymphocytes . Data are exp-
ressed as absorbance (mU) difference of T lymph-
ocytes death between activation only and anti- Fas
antibody treatment at indicated time points .
Fig . 5 . Gel analysis of genomic DNA extracted from 3-
day activated T lymphocytes.
D IS C US S IO N
Clinical and laboratory evidence suggests that hemato-
poietic failure in AA is likely to be mediated by cytotoxic
T lymphocytes that are detectable in blood and marrow.
These cells produce the inhibitory cytokine r- interferon
and tumor necrosis factor-β , both of which induce cell
death in the CD34+ components 12 ). Although findings of
lymphocyte activation have been broadly confirmed, the
biologic characteristics of self- reactive, cytotoxic T lym-
phocytes are not precisely defined.
Under various experimental conditions, activation- in-
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duced cell death can be triggered in vivo and in vitro in
mature peripheral T lymphocytes1, 13) Several studies have
previously reported that monoclonal antibodies directed
the CD3/TCR complex and mitogenic lecitins , such as
PHA, activate resting T lymphocytes but induce cell
death. These observations lend s upport to the notion that
apoptosis may play an important role in the regulation of
cellular immune response. In addition, the elimination of
antigen- reactive T lymphocytes by apoptos is may be one
of several mechanis ms that contribute to the establish-
ment of tolerance in the peripheral immune system.
Apoptosis is believed to play an important role in the
deletion of autoreactive or unwanted T lymphocytes in
two different phases during the ontogeny of the immune
response. First, the encounter of self- antigens in the
thymus leads to T lymphocytes deletion characterized by
apoptotic cell death. Thymic T lymphocytes death, how-
ever, appears to be independent of Fas antigen, because
mice homozygous for the lpr mutation, which results in
expression of a defective Fas molecule6 , 14 ), appears to
delete autoreactive T lymphocytes in a normal manner15 ).
Second, chronically stimulated mature T lymphocytes can
be eliminated in the periphery by the process of AICD1).
Several groups showed that peripheral clonal deletion
and the elimination of activated T lymphocytes are im-
paired in lpr mice 16 , 17 ), and recent analyses of AICD of T
lymphocytes demonstrated that antagonists of Fas are
able to block AICD induced by CD3 antibody, or by
phorbol ester plus calcium ionophore, or by staphy-
lococcal enterotoxin B (SEB) supernant (Alderson et al.
1995). These results show that Fas system is critically
involved in AICD of mature T lymphocytes, and it seems
likely that Fas system is the prime mediator of the
peripheral deletion of T lymphocytes and maintenance of
peripheral self- tolerance.
We have used the sensitive ELISA method for deter-
mination of cytoplasmic histone- associated DNA frag-
ments to assess cell death of human T lymphocytes by
activation with IL- 2 and PHA, and have confirmed the
presence of cell death in these cells by gel analys is . Our
data confirm the work of others that normal lymphocytes
gradually undergo apoptosis when activatedl8 , 19 ). The
major finding of this study is that T lymphocytes derived
from patients with AA undergo more delayed AICD than
T lymphocytes from normal controls . In addition to
delayed AICD, T lymphocytes from newly- diagnosed AA
patients also exhibited a delayed increase of Fas antigen
expression by activation, and decreased sensitivity to
anti- Fas antibody than normal controls . These res ults
s uggest that abnormal Fas system might be res ponsible
for delayed AICD and, eventually, autoreactivity of T
lymphocytes in AA.
IST reduces the activated lymphocyte numbers in
recovered patients 2 0 , 2 1). In some series , the inhibitory ac-
tivity of T lymphocytes has disappeared after immunos-
uppress ive therapy2 2 , 2 3). But the s pecific target subsets of
T lymphocytes to IST is unknown. Considering our re-
s ults that delayed AICD and decreased Fas antigen
express ion by activation of T lymphocytes from AA were
recovered to normal range after successful IST, IST may
eliminate this abnormal T cell clone showing delayed
AICD.
The findings of typical DNA fragmentation of AICD in
newly- diagnosed AA indicate that delayed AICD in AA is
more associated with abnormal regulation of Fas antigen
express ion than Fas- signaling defects . Recently, it has
been determined that there is an inverse express ion
between bcl- 2 and Fas antigen in activated lymphocytes.
Further studies will be required to verify the role of bcl-2
and other molecules on the expression of Fas antigen in
AA.
Although it remains important to address the under-
lying defect of delayed AICD of T lymphocytes in AA, our
data suggest that the delayed AICD associated with
abnormal Fas system might be responsible for immune
pathophys iology of AA. Until further information on in vivo
apoptos is in AA patients is revealed, it will remain
unclear whether delayed AICD is observed in vivo. Also
it is not apparent that abnormal AICD is pathogenic for
all AA patients . Further investigation of apoptos is in AA
may yield important new insights into the fundamental
pathogenesis of this disease.
R E F E R E NC E S
1. Janssen O, Wesselborg S, Heckl- Ostericher B, Pechhold
K, Bender A, Schondelmaier S, Moldenhauer G, Kabelitz
D: T cell receptor/ CD3-signaling induces death by apop -
tosis in human T cell receptor γδ+ T cells. J Immunol
1991; 146:35.
2. DAdamio L, Awad KM, Reinherz EL: Thymic and periph-
eral apoptosis of antigen-specific T cells might cooperate in
establishing self tolerance. Eur J Immunol 1993; 23:747.
3. Kabelitz D, Polhl T, Pechhold K: Activation- induced cell
death (apoptosis) of mature peripheral T lymphocytes.
Immunology Today 1993; 14:338.
4. Watanabe- Fukunaga R, Brannan CI, Itoh N, Yonehara
S, Copeland NG, Jenkins NA, Nagata S: The cDNA
45
S.C. KIM, Y.H. MIN, S . LEE, S .Y. CHUNG, N.C. YOO, J.W. LEE, J.S . HAHN, Y.W. KO
stucture, expression and chrom osomal assignm ent of the
mouse Fas antigen. J Immunol 1992; 148:1274.
5. Shigekazu N & Takashi S: Fas and Fas ligand: Ipr and
gld m utations. Immunol Today 1995; 16:39.
6. Watanabe- Fukunaga R, Brannnan CI, Copeland NG,
Jenkins NA, Nagata S: Lymphoproliferation disorder in
mice explained by defects in Fas antigen that mediates
apoptosis. Nature 1992; 356:314.
7. Bacigalupo A, Broccia G, Corda G, Arcese W, Caro-
tenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P,
Todeschini G, Coser P, Lacopino P, van Lint MT, Gluck-
man E: Antithym ocy te Slobulin, cyclosporin and granu-
locy te colony - stimulaing factor in patients with acquired
severe aplastic anemia (SAA): a pilot study of the EBMT
SAA working party. Blood 1985; 85: 1348.
8. Rosenfeld S, Kimball J , Vining D, Young NS: Improved
response rate of severe aplastic anemia to intensive
immunosuppression with antithym ocy te globulin and
cyclosporin. Blood 1995; 85:3058.
9. Young NS & Barrett AJ : The treatment of severe aplastic
anemia. Blood 1995; 85:3367.
10. Maciejewski J P, Selleri C, Sate T, Anderson S, Young
NS: Increased expression of Fas antigen on bone
marrow CD34+ cells of patients with aplastic anaemia. Bri
J Haematol, 1995; 9 1:245.
11. Akbar AN, Almot FL, Ivory K, Timms A, Janossy G:
Inhibition of alloresponsive native and mem ory T cells by
CD7 and CD25 antibodies and by Cyclosporin A. Trans-
plantation 1990; 50.823.
12. Maciejewski J P, Hibbs J R, Anderson S, Katevas P,
Young NS: Bone marrow and peripheral blood lym -
phocyte phenotype in patients with bone marrow failure.
Exp Hematol 1994; 22:1102.
13. Kabeitz D & Wesselborg S: Life and death of a superan-
tigen-reactive human CD4+ T cell clone: staphylococcal en-
terotoxins induce death by apoptosis buf simultaneously trg-
ger a proliferative response in the presence of HLA-DR+
antigen-presenting cells. Internatl Immunol 1992; 4:1381.
14. Adachi M, Watanave- Fukunaga R, Nagata S: Aberrant
transcription caused by the insertion of an early transpos -
able element in an intron of the Fas antigen gene of lpr
mice. Proc Natl Acad Sci USA 1993; 90:1756.
15 Singer PA, Balderas RS, Mcvilly RJ , Robardt M,
Theofilopoulos AN: Tolerance- related Vβ clonal dele-
tions in normal CD4- 8- , TCR-α/β - and abnormal lpr
and gld cell populations. J Exp Med 1989; 170:1869.
16. Uyama O, Matsuyama T, Michishita H, Nakamura H,
Sugita M: Protective effects of human recombinant super-
oxide dismutase on transient ishemic injury of CA 1
neurons in gerbils. S troke 1995; 23:75.
17. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler
RL: Reperfusion injury induces apoptosis in rabbit card-
iomyocytes. J Clin Invest 1994; 94:162 1.
18. Owen- Schaub LB, Yonehara S, Craump III WL, Grimm
EA: DNA fragmentation and cell death is selectively
triggered in activated human lymphocy tes by Fas antigen
engagement. Cell Immunol 1992; 140:197.
19. Sebastian W, Ottmar J , Dieter K: Induction of activation-
driven death (apoptosis) in activated but not resting peri-
pheral blood T cells. J Imm unol 1993; 150:4338.
20. Platanias L, Gascon P, Biclory L, Griffith P, Nienhuis
AW, Young NS: Lymphocyte subsets and lymphokines
following anti- thymocy te globulin therapy in patients with
aplastic anemia. Br J Haematol 1987; 66:433.
21. Lopez- Karpovitz X, Zarzosa ME, Cardenas MR, Piedras,
J : Changes in peripheral blood mononuclear cell subpo-
pulations during antithymocyte globulin therapy for severe
aplastic anemia. Acta Haematol 1989; 81:176.
22. Amare M, Abdou NL, Robinson MG, Abdou NI: Aplastic
anemia associated with bone marrow suppressor T-cell
hyperreactivity : Successful treatment with antithymocyte
globulin. Am J Hematol 1978; 5:25.
23. Hanada T, Abe T, Fukao K, Jogamoto M, Takita H.
Severe aplastic anemia treated with anti-lymphocyte
globulin. Scand J Hematol 1982; 29:128.
46
